2011

Welcome to Volume 10, Issue #4 (23 FEBRUARY 2011) of Pharma Marketing News.

David Epstein, head of Novartis Pharmaceuticals, said eighty percent of his company's sales reps will give up their PCs for iPads in 2012. Will they do it?

Welcome to Volume 10, Issue #2 (JANUARY 19, 2011) of Pharma Marketing News.

While primary care physicians in general are frequent users of the Internet, oncologists see online sources of information as more important than PCPs and therefore may need less personal contact to learn about products. That was just one of the results from the 2011 Digital Life survey of 1,454 physicians summarized is this article.

Rules for Third-Party Engagement in Patient/Physician Social Networks. A Social Media Policy is not just an agreement that users must abide by. More importantly, it is a PROMISE to users from site owners/sponsors concerning how they will protect or attempt to protect user-generated content, personal conversations, interactions, and engagements with third-parties on the site. These policies should comply with as-yet-to-be-determined, universally accepted 'fair social media practice principles.'

Should a PR firm or an interactive marketing agency be in charge of pharma social media campaigns?

Lipitor Won't Go Gentle Into that Good Generic Night. Pfizer is taking a number of steps to protect it's Lipitor franchise and it hopes that many patients currently taking Lipitor will remain loyal to the brand.

Welcome to Volume 10, Issue #11 (21 JUNE 2011) of Pharma Marketing News.

Welcome to Volume 10, Issue #11 (21 JUNE 2011) of Pharma Marketing News.

FDA's revised draft guidance calendar for year 2011 is missing 'Promotion of Prescription Drug Products Using Social Media Tools,